Table 1.
Variables | Patients (n = 374) |
---|---|
Age (y), mean ± SD | 63.4 ± 12.7 |
Female, n (%) | 93 (25) |
Type of atrial fibrillation, n (%) | |
Paroxysmal | 180 (48) |
Persistent | 105 (28) |
Permanent | 57 (15) |
Unspecified | 32 (9) |
CHF, n (%) | 93 (25) |
Hypertension, n (%) | 222 (59) |
Age ≥ 75, n (%) | 70 (19) |
Diabetes mellitus, n (%) | 51 (14) |
Prior stroke/TIA, n (%) | 55 (15) |
Vascular disease, n (%) | 97 (27) |
Age 65-74, n (%) | 100 (27) |
CHA2DS2-VASc score, mean ± SD | 2.4 ± 2.0 |
Score 0, n (%) | 57 (16) |
Score 1, n (%) | 96 (26) |
Score 2-6, n (%) | 196 (54) |
Score > 6, n (%) | 14 (4) |
Spontaneous echocardiographic contrast (SEC), n (%) | 200 (54) |
Mild | 96 (26) |
Moderate | 70 (19) |
Severe | 34 (9) |
Left atrium appendage thrombus (LAAT), n (%) | 19 (5) |
Left atrium appendage emptying velocity (cm/s), mean ± SD | 46.9 ± 25.2 |
≥ 75, n (%) | 52 (17) |
50-74, n (%) | 81 (26) |
26-49, n (%) | 96 (31) |
≤ 25, n (%) | 78 (25) |
Left atrium volume index (cm/m2), mean ± SD | 43.3 ± 16.6 |
> 60, n (%) | 44 (14) |
Left ventricular ejection fraction, mean ± SD | 54.8 ± 11.6 |
< 40%, n (%) | 40 (11) |
Any atheromas of aorta, n (%) | 237 (65) |
Simple | 209 (57) |
Severe | 28 (8) |
VWF activity (IU/dL) | |
Mean (SD) | 145.9 (51.5) |
Median (min, max) | 136.8 (49.2, 375.2) |
VWF antigen (IU/dL) | |
Mean (SD) | 159.6 (53.4) |
Median (min, max) | 155.0 (49.0, 399.0) |
VWF activity/antigen concentration ratio | |
Mean (SD) | 0.9 (0.1) |
Median (min, max) | 0.9 (0.6, 1.5) |
ADAMTS13 activity | |
Mean (SD) | 115.8 (46.0) |
Median (min, max) | 109.3 (30.7, 289.3) |
ADAMTS13, a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13; CHA2DS2-VASc, Congestive Heart Failure, Hypertension, Age (≥75 years), Diabetes, Stroke/Transient Ischemic Attack, Vascular Disease, Age (65-74 years), Sex (Female); CHF, congestive heart failure; SD, standard deviation; TIA, transient ischemic attack; VWF, Von Willebrand factor.